Article information
Full text is only aviable in PDF
References
[1]
M Christ-Crain, B Müller.
Biomarkers in respiratory infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators.
Eur Respir J, 30 (2007), pp. 556-573
[2]
PK Lindenauer, P Pekow, S Gao, AS Crawford, B Gutiérrez, EM Benjamin.
Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease.
Ann Intern Med, 114 (2006), pp. 894-903
[3]
S Nseir, C di Pompeo, B Cavestri, E Jozefowicz, M Nyunga, S Soubrier, et al.
Multidrug resistant bacteria in patients with acute severe exacerbations of chronic obstructive pulmonary disease: prevalence, risk factors and outcomes.
Am J Respir Crit Care Med, 34 (2006), pp. 2959-2966
[4]
F Ram, R Rodríguez Roisin, A Granados Navarrete, J García-Aymerich, NC Barnes.
Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Acute Respiratory Infections Group.
Cochrane Database Syst Rev, (2006),
[5]
RA Stockley, C O'Brien, A Pye, SL Hill.
Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD.
Chest, 117 (2000), pp. 1638-1645
[6]
P van der Valk, E Monninkhof, J van der Palen, G Zielhuis, C van Herwaarden, R Hendrix.
Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease.
Clin Infect Dis, 39 (2004), pp. 980-986
[7]
N Soler, C Agustí, J Angrill, J Puig de la Bellacasa, A Torres.
Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease (COPD).
Thorax, 62 (2007), pp. 29-35
[8]
D Stolz, M Christ-Crain, NG Morgenthaler, J Leuppi, D Miedinger, R Bingisser, et al.
Co-peptin, C-reactive protein and procalcitonin as prognostic biomarkers in acute exacerbation of COPD.
Chest, 131 (2007), pp. 1058-1067
[9]
Stolz D, Christ-Crain M, Morgenthaler NG, Miedinger D, Leuppi J, Müller C, et al. Plasma pro-adrenomedullin but not proendothelin predicts survival in exacerbations of COPD. Chest. At press 2008.
[10]
N Weis, T Almdal.
C-reactive protein – can it be used as a marker of infection in patients with exacerbation of chronic obstructive pulmonary disease?.
Eur J Intern Med, 17 (2004), pp. 88-91
[11]
L Simon, F Gauvin, DK Amre, P Saint-Louis, J Lacroix.
Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis.
Clin Infect Dis, 39 (2004), pp. 206-217
[12]
D Stoltz, M Christ-Crain, R Bingisser, J Leuppi, D Miedinger, C Müller, et al.
Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonic-guidance with standard therapy.
Chest, 131 (2007), pp. 9-19
[13]
B Müller, N Morgenthaler, D Stolz, P Schuetz, C Muller, R Bingisser, et al.
Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections.
Eur J Clin Invest, 37 (2007), pp. 145-152
Copyright © 2008. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
